Allium hookeri Inhibits Inflammation in OVA-induced Allergic Rhinitis in Mice via NF-κB Pathway
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Allium hookeri (A. hookeri) has been used as a traditional medicine for many years in the Southeast Asian region. Multiple investigations have demonstrated its role in preventing of microbial infection, immune regulation, coronary thrombosis, and atherosclerosis has been demonstrated by several studies. Therefore, this study aims to investigate the suppressing effect of A. hookeri on the ovalbumin (OVA)-induced allergic rhinitis (AR) murine model. In this study, AR was induced in BALB/c mice by using OVA emulsified in aluminum on days 1, 8 and 15. Then, nasally challenged with OVA on days 22 to 28. On days 16 to 28, OVA-induced mice were treated either with A. hookeri (50, 100, 200 mg/kg) or Dexamethasone (Dex, 2.5 mg/kg) by oral gavage. On days 22 to 28, mice received either A. hookeri (50, 100, 200 mg/kg) or Dexamethasone (Dex, 2.5 mg/kg) an hour before the OVA challenge. The mice in the control group were not sensitized, treated, or tested. In this study, A. hookeri ameliorated nasal symptoms include rubbing and sneezing; reduced thickness of nasal mucosa; alleviated goblet cell hyperplasia and eosinophil infiltration in the nasal mucosa; decreased levels of OVA-specific IgE and OVA-specific IgG1 in serum; and suppressed Th2 (IL-4, IL-5, and IL-13) cytokines level in nasal lavage fluid (NALF). In addition, A. hookeri recovered the production of Th1 (IL-12 and IFN-γ) cytokines level in NALF, inhibited the inflammation through NF-κB pathway. Collectively, our results suggest that A. hookeri effectively protects against AR by regulating Th1/Th2 cytokines imbalance and NF-κB mechanisms. These observations suggest A. hookeri as a potential therapeutic option for AR.
Abstract
Allium hookeri (A. hookeri) has been used as a traditional medicine for many years in the Southeast Asian region. Multiple investigations have demonstrated its role in preventing of microbial infection, immune regulation, coronary thrombosis, and atherosclerosis has been demonstrated by several studies. Therefore, this study aims to investigate the suppressing effect of A. hookeri on the ovalbumin (OVA)-induced allergic rhinitis (AR) murine model. In this study, AR was induced in BALB/c mice by using OVA emulsified in aluminum on days 1, 8 and 15. Then, nasally challenged with OVA on days 22 to 28. On days 16 to 28, OVA-induced mice were treated either with A. hookeri (50, 100, 200 mg/kg) or Dexamethasone (Dex, 2.5 mg/kg) by oral gavage. On days 22 to 28, mice received either A. hookeri (50, 100, 200 mg/kg) or Dexamethasone (Dex, 2.5 mg/kg) an hour before the OVA challenge. The mice in the control group were not sensitized, treated, or tested. In this study, A. hookeri ameliorated nasal symptoms include rubbing and sneezing; reduced thickness of nasal mucosa; alleviated goblet cell hyperplasia and eosinophil infiltration in the nasal mucosa; decreased levels of OVA-specific IgE and OVA-specific IgG1 in serum; and suppressed Th2 (IL-4, IL-5, and IL-13) cytokines level in nasal lavage fluid (NALF). In addition, A. hookeri recovered the production of Th1 (IL-12 and IFN-γ) cytokines level in NALF, inhibited the inflammation through NF-κB pathway. Collectively, our results suggest that A. hookeri effectively protects against AR by regulating Th1/Th2 cytokines imbalance and NF-κB mechanisms. These observations suggest A. hookeri as a potential therapeutic option for AR.
참고문헌 (41)
- 조성우, "Intranasal Treatment With 1, 25-Dihydroxyvitamin D3 Alleviates Allergic Rhinitis Symptoms in a Mouse Model", Allergy, Asthma & Immunology Research, 11(2), pp.267~279 (2019), 대한천식알레르기학회
- Yu-Lian Zhang, "Antiallergic Effect of Hizikia fusiformis in an Ovalbumin-Induced Allergic Rhinitis Mouse Model", Clinical and Experimental Otorhinolaryngology, 12(2), pp.196~205 (2019), 대한이비인후과학회[DOI]
- Xiang R, "Semaphorin 3A inhibits allergic inflammation by regulating immune responses in a mouse model of allergic rhinitis", Int Forum Allergy Rhinol, 9, pp.528~537 (2019)[DOI]
- Smarr CB, "Antigen-specific tolerance in immunotherapy of Th2-associated allergic diseases", Crit Rev Immunol, 33, pp.389~414 (2013)[DOI]
- Galli SJ, "The development of allergic inflammation", Nature, 454, pp.445~454 (2008)[DOI]
- Manikandan J, "Deciphering the structure and function of FcepsilonRI", mast cell axis in the regulation of allergy and anaphylaxis : a functional genomics paradigm, 2012, pp.69, 1917~1929
- Fu Y, "Mesenchymal stem cells combined with traditional Chinese medicine(qi-fang-bi-min-tang)alleviates rodent allergic rhinitis", J Cell Biochem, 121, pp.1541~1551 (2020)[DOI]
- Gu X, "Pinocembrin attenuates allergic airway inflammation via inhibition of NF-κB pathway in mice", Int immunopharmacol, 53, pp.90~95 (2017)
- Ghosh S, "NF-κB and Rel proteins : evolutionarily conserved mediators of immune responses", Annu Rev Immunol, 16, pp.225~260 (1998)
- Bing Z, "Effect of Astragalus membranaceus in Ovalbumin-Induced Allergic Rhinitis Mouse Model", Am J Rhinol Allergy, 33, pp.420~432 (2019)[DOI]
- Shilin G, "Alleviation effects of lycoperdon pedicellatum peck on lipopolysaccharide-induced acute lung injury in mice", Evid-based Complement Altern Med, 501, pp.1809715~ (2016)
- Shi HL, "Expression profiles of PI3K, NF-κB, and STAT1 in peripheral blood mononuclear cells in children with bronchial asthma", Zhongguo Dang Dai Er Ke Za Zhi, 18, pp.614~617 (2016)
- Gao Y, "Abietic acid attenuates allergic airway inflammation in a mouse allergic asthma model", Int Immunopharmacol, 38, pp.261~266 (2016)[DOI]
- Okubo K, "Japanese guidelines for allergic rhinitis 2017", Allergol Int, 66, pp.205~219 (2017)[DOI]
- May JR, "Management of Allergic Rhinitis : A Review for the Community Pharmacist", Clin Ther, 39, pp.2410~2419 (2017)[DOI]
- Gonzalez-Nunez V, "Rupatadine : global safety evaluation in allergic rhinitis and urticaria", Expert Opin Drug Saf, 15, pp.1439~1448 (2016)[DOI]
- Nosulya EV, "The modern strategies for the treatment of allergic rhinitis", Vestn Otorinolaringol, 81, pp.74~76 (2016)[DOI]
- Ricketti PA, "Investigational new drugs for allergic rhinitis", Expert Opin Investig Drugs, 26, pp.279~292 (2017)[DOI]
- Santos CB, "Allergic rhinitis and its effect on sleep, fatigue, and daytime somnolence", Ann Allergy Asthma Immunol, 97, pp.579~586 (2006)[DOI]
- 전현일, "삼채 뿌리 열수 농축물을 첨가한 발효유의 품질특성", 한국식품영양과학회지, 43(9), pp.1415~1422 (2014), 한국식품영양과학회
- Sharma G, "Cytological status of Allium hookeri Thwaites(2n= 22)", Genet Resour Crop Evol, 58, pp.1041~1050 (2011)
- Kyung KH, "Antimicrobial properties of allium species", Curr Opin Biotechnol, 23, pp.142~147 (2012)
- 박세연, "Anti-Obesity Effect of Allium hookeri Leaf Extract in High-Fat Diet-Fed Mice", Journal of Medicinal Food, 21(3), pp.254~260 (2018), 한국식품영양과학회[DOI]
- 황정승, "삼채의 잎, 인경, 뿌리의 총페놀 함량, 총플라보노이드 함량 및 항산화능", 한국식품과학회지, 47(2), pp.261~266 (2015), 한국식품과학회[DOI]
- 배기춘, "국내산 삼채 에탄올 추출물의 항염증 효과", 대한본초학회지, 27(6), pp.55~61 (2012), 대한본초학회
- Kim H-Y, "Protective effects of rutin through regulation of vascular endothelial growth factor in allergic rhinitis", Am J Rhinol Allergy, 29, pp.e87~e94 (2015)
- Lee SY, "Anti-inflammatory Effect of Curcuma longa and Allium hookeri Cotreatment via NF-κB and COX-2 Pathways", Sci Rep, 10, pp.5718~ (2020)[DOI]
- Park SH, "A randomized, double-blind, placebo-controlled crossover clinical trial to evaluate the anti-diabetic effects of Allium hookeri extract in the subjects with prediabetes", BMC Complement Med Ther, 20, pp.211~ (2020)[DOI]
- Fan Y, "Gallic acid alleviates nasal inflammation via activation of Th1and inhibition of Th2 and Th17 in a mouse model of allergic rhinitis", Int Immunopharmacol, 70, pp.512~519 (2019)[DOI]
- Li C, "Mesenchymal stromal cells ameliorate acute allergic rhinitis in rats", Cell Biochem Funct, 35, pp.420~425 (2017)[DOI]
- Head K, "Saline irrigation for allergic rhinitis", Cochrane Database Syst Rev, 6, pp.CD012597~ (2018)[DOI]
- Mygind N, "Glucocorticosteroids and rhinitis", Allergy, 48, pp.476~490 (1993)
- Resnick ES, "Complementary therapy in allergic rhinitis", Curr Allergy Asthma Rep, 8, pp.118~125 (2008)[DOI]
- Shao Y-Y, "The anti-allergic rhinitis effect of traditional Chinese medicine of Shenqi by regulating mast cell degranulation and Th1", Th2 cytokine balance, 2017, pp.22, 504~
- Ivanova EA, "T Helper Lymphocyte Subsets and Plasticity in Autoimmunity and Cancer : An Overview", Biomed Res Int, 2015, pp.327470~ (2015)[DOI]
- Hellings PW, "Eosinophilic rhinitis accompanies the development of lower airway inflammation and hyper-reactivity in sensitized mice exposed to aerosolized allergen", Clin Exp Allergy, 31, pp.782~790 (2001)[DOI]
- Hussain I, "Induction, distribution and modulation of upper airway allergic inflammation in mice", Clin Exp Allergy, 31, pp.1048~1059 (2001)[DOI]
- Saito H, "Pathogenesis of murine experimental allergic rhinitis : a study of local and systemic consequences of IL-5deficiency", J Immunol, 168, pp.3017~3023 (2002)[DOI]
- Oestreich KJ, "Transcriptional mechanisms that regulate T helper 1 cell differentiation", Curr Opin Immunol, 24, pp.191~195 (2012)[DOI]
- Fan XH, "Ameliorative effect of acetylshikonin on ovalbumin (OVA)-induced allergic rhinitis in mice through the inhibition of Th2 cytokine production and mast cell histamine release", APMIS, 127, pp.688~695 (2019)[DOI]
- Maekawa Y, "Klotho suppresses TNF-alpha-induced expression of adhesion molecules in the endothelium and attenuates NF-kappaB activation", Endocrine, 35, pp.341~346 (2009)[DOI]